Avanos Medical, Inc. P/E Ratio 2012–2025
Avanos Medical, Inc. reported 25.29 of price-to-earnings ratio for fiscal 2022. That was 90.5% lower than fiscal 2021. Compared with fiscal 2017, the change was -7.4%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | — | — |
| FY 2024 | — | — |
| FY 2023 | — | — |
| FY 2022 | 25.29 | -90.5% |
| FY 2021 | 266.69 | — |
| FY 2020 | — | — |
| FY 2019 | — | — |
| FY 2018 | 36.71 | +34.4% |
| FY 2017 | 27.33 | -37.2% |
| FY 2016 | 43.51 | — |
| FY 2015 | — | — |
| FY 2014 | 78.40 | — |
| FY 2013 | — | — |
| FY 2012 | — | — |
Source: Avanos Medical, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open AVNS 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Avanos Medical, Inc. reported 25.29 of price-to-earnings ratio for fiscal 2022. That was 90.5% lower than fiscal 2021. Compared with fiscal 2017, the change was -7.4%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Avanos Medical, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAvanos Medical, Inc. — frequently asked questions
What is Avanos Medical, Inc.'s price-to-earnings ratio?
Avanos Medical, Inc. (AVNS) reported price-to-earnings ratio of 25.29 for fiscal year 2022, per its SEC filings.
How has Avanos Medical, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2012 and 2025, AVNS's price-to-earnings ratio declined at roughly 8.3% per year (compound annual rate), from 78.40 to 25.29.
Where does this data come from?
Figures are computed from Avanos Medical, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More AVNS financial history
Full AVNS fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →